Certis Oncology Solutions, Inc

Certis Oncology Solutions is a life science technology company with a mission to realize the promise of precision oncology. Our product is Oncology IntelligenceTM highly predictive therapeutic response data derived from proprietary biological models of cancer. We apply these models to machine learning and AI-enhanced predictive algorithms, the development of the next generation of targeted cancer therapeutics, and functional precision medicine. Established in 2016, Certis began its journey in functional precision oncology, helping cancer patients and their oncologists through YourPDXTM testing. ACCELERATING THE DEVELOPMENT OF NEW CANCER THERAPIES Certis partners with therapeutic developers to help close the problematic translational gap...

Oncology,in vivo research,pre-clinical services,oncology services,clinical research organization,cro,pdx,patient derived xenografts,orthotopic pdx,precision oncology,personalized medicine,artificial intelligence,cancer research,preclinical studies,translational science,oncology intelligence,3d cell cultures,advanced imaging,immuno-oncology,io,histology,mouse models,preclinical drug development,and preclinical research

Certis oncology solutions, inc's revenue is 1m - 10m

Certis oncology solutions, inc has 11 - 50 employees.